ADVM - Adverum Biotechnologies, Inc.
2.81
-0.310 -11.032%
Share volume: 354,095
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.12
-0.31
-0.10%
Summary score
17%
Profitability
0%
Dept financing
11%
Liquidity
40%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-11.45%
Return on sales
-1881.04%
Return on invested capital
0%
Total debt ratio
39.65%
Debt ratio change over timeo
0%
Current Ratio
6.54%
Quick Ratio
0%
Cash Position Ratio
3.5%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-10.47%
Return on sales
-2922.1%
Return on invested capital
0%
Total debt ratio
39%
Debt ratio change over timeo
0%
Current Ratio
6.79%
Quick Ratio
0%
Cash Position Ratio
4.74%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-11.47%
Return on sales
-2922.1%
Return on invested capital
0%
Total debt ratio
38.51%
Debt ratio change over time
0%
Current Ratio
5.82%
Quick Ratio
0%
Cash Position Ratio
3.36%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ADVM | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 18.34% | 6.69% | 16.49% |
| Return on assets | -11.45% | 3.17% | 3.1% | 15.3% |
| Return on sales | -1881.04% | 30.73% | 28.93% | 7.81% |
| Return on invested capital | 0% | 5.33% | 3.55% | -56.8% |
| Profitability | 0% | 80% | 54% | 54% |
| Total debt ratio | 39.65% | 91.7% | 67.67% | 20.78% |
| Debt ratio change over time | 0% | 20.48% | 127.93% | -1.07% |
| Dept financing | 11% | 29% | 43% | 6% |
| Current Ratio | 6.79% | 1.41% | 1.23% | 10.4% |
| Quick Ratio | 0% | 0.99% | 1.06% | 10.21% |
| Cash Position Ratio | 4.74% | 0.49% | 0.42% | 5.61% |
| Liquididy | 47% | 18% | 13% | 75% |
| Short-term ratios | ADVM | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 6.26% | 0.37% |
| Return on assets | -10.47% | 2.14% | 0.55% | 0.13% |
| Return on sales | -2922.1% | 18.91% | 3.35% | -117.21% |
| Return on invested capital | 0% | 0% | 4.11% | 10% |
| Profitability | 0% | 50% | 46% | 28% |
| Total debt ratio | 39% | 93.35% | 66.02% | 11.14% |
| Debt ratio change over time | 0% | 0% | 12.37% | -0.23% |
| Dept financing | 10% | 25% | 43% | 3% |
| Current Ratio | 6.79% | 1.41% | 1.23% | 10.4% |
| Quick Ratio | 0% | 0.99% | 1.06% | 10.21% |
| Cash Position Ratio | 4.74% | 0.49% | 0.42% | 5.61% |
| Liquididy | 37% | 8% | 7% | 75% |
